The dawn of active genetics

BioEssays

Volumn 38, Issue 1, 2016, Pages 50-63

  Gantz, Valentino M ^a   Bier, Ethan ^a  

^a SECTION OF CELL AND DEVELOPMENTAL BIOLOGY   (United States)

Author keywords

Active genetics; Copy cat element; Drosophila; ERACR; Gene drive; MCR; Mutagenic chain reaction

Indexed keywords

BIOSAFETY; CHROMOSOME; GENE AMPLIFICATION; GENE MUTATION; GENE THERAPY; GENETICS; INHERITANCE; MOSQUITO; MUTATION; YEAST; ALLELE; ANIMAL; CRISPR CAS SYSTEM; DROSOPHILA MELANOGASTER; FEMALE; GENE EDITING; MALE; PHENOTYPE; RECESSIVE GENE; TRANSGENIC ANIMAL;

ALLELES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CHROMOSOMES; CRISPR-CAS SYSTEMS; DROSOPHILA MELANOGASTER; FEMALE; GENE EDITING; GENES, RECESSIVE; MALE; MUTATION; PHENOTYPE;

EID: 84956762535     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201500102     Document Type: Article

References (76)

1. Barrangou R. 2015. The roles of CRISPR-Cas systems in adaptive immunity and beyond. Curr Opin Immunol 32: 36-41.
2. Gasiunas G, Sinkunas T, Siksnys V. 2014. Molecular mechanisms of CRISPR-mediated microbial immunity. Cell Mol Life Sci 71: 449-65.
3. Westra ER, Buckling A, Fineran PC. 2014. CRISPR-Cas systems: beyond adaptive immunity. Nat Rev Microbiol 12: 317-26.
4. Jiang F, Doudna JA. 2015. The structural biology of CRISPR-Cas systems. Curr Opin Struct Biol 30: 100-111.
5. Bassett AR, Liu JL. 2014. CRISPR/Cas9 and genome editing in Drosophila. J Genet Genom 41: 7-19.
6. Zhang F, Wen Y, Guo X. 2014. CRISPR/Cas9 for genome editing: progress, implications and challenges. Hum Mol Genet 23: R40-6.
7. Hsu PD, Lander ES, Zhang F. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell 157: 1262-78.
8. Sander JD, Joung JK. 2014. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 32: 347-55.
9. Sternberg SH, Doudna JA. 2015. Expanding the biologist's toolkit with CRISPR-Cas9. Mol Cell 58: 568-574.
10. Doudna JA, Charpentier E. 2014. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346: 1258096.
11. Overcash JM, Aryan A, Myles KM, Adelman ZN. 2015. Understanding the DNA damage response in order to achieve desired gene editing outcomes in mosquitoes. Chromosome Res 23: 31-42.
12. Chiruvella KK, Liang Z, Wilson TE. 2013. Repair of double-strand breaks by end joining. Cold Spring Harb Perspect Biol 5: a012757.
13. Aylon Y, Kupiec M. 2004. DSB repair: the yeast paradigm. DNA Repair (Amst) 3: 797-815.
14. Jasin M, Rothstein R. 2013. Repair of strand breaks by homologous recombination. Cold Spring Harb Perspect Biol 5: a012740.
15. Kondo S, Ueda R. 2013. Highly improved gene targeting by germline-specific Cas9 expression in Drosophila. Genetics 195: 715-21.
16. Port F, Chen HM, Lee T, Bullock SL. 2014. Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila. Proc Natl Acad Sci USA 111: E2967-76.
17. Sebo ZL, Lee HB, Peng Y, Guo Y. 2014. A simplified and efficient germline-specific CRISPR/Cas9 system for Drosophila genomic engineering. Fly (Austin) 8: 52-7.
18. Ren X, Sun J, Housden BE, Hu Y, et al. 2013. Optimized gene editing technology for Drosophila melanogaster using germ line-specific Cas9. Proc Natl Acad Sci USA 110: 19012-7.
19. Gratz SJ, Wildonger J, Harrison MM, O'Connor-Giles KM. 2013. CRISPR/Cas9-mediated genome engineering and the promise of designer flies on demand. Fly (Austin) 7: 249-55.
20. Gratz SJ, Ukken FP, Rubinstein CD, Thiede G, et al. 2014. Highly specific and efficient CRISPR/Cas9-catalyzed homology-directed repair in Drosophila. Genetics 196: 961-71.
21. Yu Z, Chen H, Liu J, Zhang H, Yan Y, et al. 2014. Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome. Biol Open 3: 271-80.
22. Gantz VM, Bier E. 2015. The mutagenic chain reaction: a method for converting heterozygous to homozygous mutations. Science 348: 442-4.
23. Gantz V, Jasinskiene N, Tatarenkova O, Fazekas A, et al. 2015. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito, Anohpeles stepensi. Proc Natl Acad Sci USA, doi: 10.1073/pnas.1521077112.
24. DiCarlo JE, Chavez A, Dietz SL, Esvelt KM, et al. 2015. RNA-guided gene drives can efficiently bias inheritance in wild yeast. bioRxiv.
25. Bassett AR, Tibbit C, Ponting CP, Liu JL. 2013. Highly efficient targeted mutagenesis of Drosophila with the CRISPR/Cas9 system. Cell Rep 4: 220-8.
26. Esvelt KM, Smidler AL, Catteruccia F, Church GM. 2014. Concerning RNA-guided gene drives for the alteration of wild populations. eLife 2014: e03401.
27. Do AT, Brooks JT, Le Neveu MK, LaRocque JR. 2014. Double-strand break repair assays determine pathway choice and structure of gene conversion events in Drosophila melanogaster. G3 (Bethesda) 4: 425-32.
28. Curtis CF. 1968. Possible use of translocations to fix desirable genes in insect pest populations. Nature 218: 368-9.
29. James AA. 2005. Gene drive systems in mosquitoes: rules of the road. Trends Parasitol 21: 64-7.
30. Burt A. 2014. Heritable strategies for controlling insect vectors of disease. Philos Trans R Soc Lond B Biol Sci 369: 20130432.
31. Alphey L, McKemey A, Nimmo D, Neira Oviedo M, et al. 2013. Genetic control of Aedes mosquitoes. Pathog Glob Health 107: 170-9.
32. Marshall JM. 2009. The effect of gene drive on containment of transgenic mosquitoes. J Theor Biol 258: 250-65.
33. Sinkins SP, Gould F. 2006. Gene drive systems for insect disease vectors. Nat Rev Genet 7: 427-35.
34. Skipper KA, Andersen PR, Sharma N, Mikkelsen JG. 2013. DNA transposon-based gene vehicles - scenes from an evolutionary drive. J Biomed Sci 20: 92.
35. Ward CM, Su JT, Huang Y, Lloyd AL, et al. 2011. Medea selfish genetic elements as tools for altering traits of wild populations: a theoretical analysis. Evolution 65: 1149-62.
36. Chen CH, Huang H, Ward CM, Su JT, et al. 2007. A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila. Science 316: 597-600.
37. Akbari OS, Chen CH, Marshall JM, Huang H, et al. 2014. Novel synthetic Medea selfish genetic elements drive population replacement in Drosophila; a theoretical exploration of Medea-dependent population suppression. ACS Synth Biol 3: 915-28.
38. Alphey N, Bonsall MB. 2014. Interplay of population genetics and dynamics in the genetic control of mosquitoes. J R Soc Interface 11: 20131071.
39. Deredec A, Godfray HC, Burt A. 2011. Requirements for effective malaria control with homing endonuclease genes. Proc Natl Acad Sci USA 108: E874-80.
40. Windbichler N, Menichelli M, Papathanos PA, Thyme SB, et al. 2011. A synthetic homing endonuclease-based gene drive system in the human malaria mosquito. Nature 473: 212-5.
41. Akbari OS, Matzen KD, Marshall JM, Huang H, et al. 2013. A synthetic gene drive system for local, reversible modification and suppression of insect populations. Curr Biol 23: 671-7.
42. Rasgon J. 2007. Population replacement strategies for controlling vector populations and the use of Wolbachia pipientis for genetic drive. J Vis Exp 2007: 225.
43. Huang Y, Magori K, Lloyd AL, Gould F. 2007. Introducing transgenes into insect populations using combined gene-drive strategies: modeling and analysis. Insect Biochem Mol Biol 37: 1054-63.
44. Sinkins SP, Godfray HC. 2004. Use of Wolbachia to drive nuclear transgenes through insect populations. Proc Biol Sci 271: 1421-6.
45. Burt A. 2003. Site-specific selfish genes as tools for the control and genetic engineering of natural populations. Proc Biol Sci 270: 921-8.
46. Deredec A, Burt A, Godfray HC. 2008. The population genetics of using homing endonuclease genes in vector and pest management. Genetics 179: 2013-26.
47. North A, Burt A, Godfray HC, Buckley Y. 2013. Modelling the spatial spread of a homing endonuclease gene in a mosquito population. J Appl Ecol 50: 1216-1225.
48. Gire SK, Goba A, Andersen KG, Sealfon RS, et al. 2014. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345: 1369-72.
49. Ito J, Ghosh A, Moreira LA, Wimmer EA, et al. 2002. Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature 417: 452-5.
50. Isaacs AT, Jasinskiene N, Tretiakov M, Thiery I, et al. 2012. Transgenic Anopheles stephensi coexpressing single-chain antibodies resist Plasmodium falciparum development. Proc Natl Acad Sci USA 109: E1922-30.
51. Isaacs AT, Li F, Jasinskiene N, Chen X, et al. 2011. Engineered resistance to Plasmodium falciparum development in transgenic Anopheles stephensi. PLoS Pathog 7: e1002017.
52. Li J, Wang X, Zhang G, Githure JI, et al. 2013. Genome-block expression-assisted association studies discover malaria resistance genes in Anopheles gambiae. Proc Natl Acad Sci USA 110: 20675-80.
53. Bryant B, Raikhel AS. 2011. Programmed autophagy in the fat body of Aedes aegypti is required to maintain egg maturation cycles. PLoS ONE 6: e25502.
54. Corby-Harris V, Drexler A, Watkins de Jong L, Antonova Y, et al. 2010. Activation of Akt signaling reduces the prevalence and intensity of malaria parasite infection and lifespan in Anopheles stephensi mosquitoes. PLoS Pathog 6: e1001003.
55. Lee YC, Langley CH. 2010. Transposable elements in natural populations of Drosophila melanogaster. Philos Trans R Soc Lond B Biol Sci 365: 1219-28.
56. Maside X, Assimacopoulos S, Charlesworth B. 2000. Rates of movement of transposable elements on the second chromosome of Drosophila melanogaster. Genet Res 75: 275-84.
57. Siliciano JD, Siliciano RF. 2013. HIV-1 eradication strategies: design and assessment. Curr Opin HIV AIDS 8: 318-25.
58. Maher RL, Branagan AM, Morrical SW. 2011. Coordination of DNA replication and recombination activities in the maintenance of genome stability. J Cell Biochem 112: 2672-82.
59. Ira G, Pellicioli A, Balijja A, Wang X, et al. 2004. DNA end resection, homologous recombination and DNA damage checkpoint activation require C DK1. Nature 431: 1011-7.
60. Escribano-Diaz C, Orthwein A, Fradet-Turcotte A, Xing M, et al. 2013. A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol Cell 49: 872-83.
61. Mousseau G, Mediouni S, Valente ST. 2015. Targeting HIV transcription: The quest for a functional cure. Curr Top Microbiol Immunol 389: 121-45.
62. Sgarbanti M, Battistini A. 2013. Therapeutics for HIV-1 reactivation from latency. Curr Opin Virol 3: 394-401.
63. Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, et al. 2015. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell 163: 759-71.
64. Heuckmann JM, Thomas RK. 2015. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine. Ann Oncol 26: 1830-7.
65. Cronin M, Ross JS. 2011. Comprehensive next-generation cancer genome sequencing in the era of targeted therapy and personalized oncology. Biomark Med 5: 293-305.
66. Venken KJ, Bellen HJ. 2014. Chemical mutagens, transposons, and transgenes to interrogate gene function in Drosophila melanogaster. Methods 68: 15-28.
67. Venken KJ, Bellen HJ. 2012. Genome-wide manipulations of Drosophila melanogaster with transposons, Flp recombinase, and PhiC31 integrase. Methods Mol Biol 859: 203-28.
68. Fonfara I, Le Rhun A, Chylinski K, Makarova KS, et al. 2014. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res 42: 2577-90.
69. Oye KA, Esvelt K, Appleton E, Catteruccia F, et al. 2014. Biotechnology. Regulating gene drives. Science 345: 626-8.
70. Lunshof J. 2015. Regulate gene editing in wild animals. Nature 521: 127.
71. Akbari BO, Bellen HJ, Bier E, Bullock SL, et al. 2015. Safeguarding gene drive experiments in the laboratory. Science 349: 927-9.
72. Ramsey JM, Bond JG, Macotela ME, Facchinelli L, et al. 2014. A regulatory structure for working with genetically modified mosquitoes: lessons from Mexico. PLoS Negl Trop Dis 8: e2623.
73. Ebina H, Misawa N, Kanemura Y, Koyanagi Y. 2013. Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus. Sci Rep 3: 2510.
74. Committee A-AD. 2001. Containment Guidelines (ver. 3.1). The American Committee of Medical Entomology of the American Society for Tropical Medicine and Hygiene.
75. Health USDoHaHSPHSCfDCaPNIo. 2009. Biosafety in Microbiological and Biomedical Laboratories 5th Edition. HHS Publication No. (CDC) 21-1112.
76. Services DoHaH. 2013. NIH guidelines for research involving recombinant or synthetic nucleic acid molecules. HHS.